Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomach Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Parathyroid Diseases 1Ovarian Neoplasms 1Osteosarcoma 1Neuroma 1Neoplasms 1Lymphatic Metastasis 1Hypoparathyroidism 1Graves Disease 1Goiter 1Giant Cell Tumor of Tendon Sheath 1Giant Cell Tumor of Bone 1Erectile Dysfunction 1Endometrial Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Anastomotic Leak 1Adenoma 1

Interventions

lenvatinib 3cabozantinib 2Thyrotropin Alfa 2vandetanib 1trametinib 1sintilimab 1selpercatinib 1pralsetinib 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1larotrectinib 1dabrafenib 1anlotinib 1acetaminophen, codeine drug combination 1Tramadol 1Thyroxine 1Technetium Tc 99m Sestamibi 1Sunitinib 1Sodium Chloride 1Ondansetron 1Negative-Pressure Wound Therapy 1Indocyanine Green 1Fentanyl 1Conversion to Open Surgery 1Capsules 1Aprepitant 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Thyroid Neoplasms × Indocyanine Green × Clear all
NCT03969108 2020-03-27

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

University Health Network, Toronto

Phase 4 Completed
10 enrolled
Head & Neck

Goiter, Graves Disease, Hypoparathyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡